title: Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome.
abstract: Bladder instillation therapy refers to the direct introduction of medication into the bladder and is a common treatment modality for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) who have failed conservative and oral therapies. The current American Urological Association (AUA) recommendations list three medications as options for IC/BPS instillation therapy: dimethyl sulfoxide, heparin, and lidocaine. The purpose of this review is to examine the evidence behind the recommendations for these medications. We also examine several historical or experimental therapies that do not hold recommendations but are still used on rare occasion. Finally, we discuss our bladder instillation strategies as well as potential future research and development in intravesicular therapy.
authors.affiliation: Department of Urology, Wake Forest University Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
authors.forename: Marc A
authors.initials: MA
authors.lastname: Colaco
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Evans
mesh_terms: D000283:Administration, Intravesical; D000818:Animals; D018856:Cystitis, Interstitial / Q000150:complications / Q000628:therapy*; D006801:Humans; D007322:Instillation, Drug; D010146:Pain / Q000209:etiology*; D059408:Pain Management / Q000379:methods / Q000592:standards*; D017410:Practice Guidelines as Topic; D013577:Syndrome